^
BIOMARKER:

EGFR mutation + EGFR amplification

i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Entrez ID:
EGFR mutation + EGFR amplification
GBM
bevacizumab + osimertinib
Sensitive: C3 – Early Trials
J Neurooncol - 2 weeks
EGFR mutation + EGFR amplification
NSCLC
EGFR inhibitor
Resistant: C3 – Early Trials